ICL Group Ltd (ICL)
| Market Cap | 7.01B |
| Revenue (ttm) | 7.15B |
| Net Income (ttm) | 226.00M |
| Shares Out | 1.29B |
| EPS (ttm) | 0.18 |
| PE Ratio | 31.64 |
| Forward PE | 14.39 |
| Dividend | $0.18 (3.25%) |
| Ex-Dividend Date | Mar 10, 2026 |
| Volume | 1,301,928 |
| Open | 5.43 |
| Previous Close | 5.54 |
| Day's Range | 5.37 - 5.44 |
| 52-Week Range | 4.76 - 7.35 |
| Beta | 0.94 |
| Analysts | Hold |
| Price Target | 6.10 (+12.34%) |
| Earnings Date | May 13, 2026 |
About ICL
ICL Group Ltd, together with its subsidiaries, operates as a specialty minerals and chemicals company worldwide. The company operates in four segments: Industrial Products, Potash, Phosphate Solutions, and Growing Solutions. The Industrial Products segment produces bromine out of a solution that is a by-product of the potash production process, as well as bromine-based compounds; sells various grades of potash, salt, magnesium chloride, and magnesia products; and produces and markets phosphorous-based flame retardants and other phosphorus-based... [Read more]
Financial Performance
In 2025, ICL Group's revenue was $7.15 billion, an increase of 4.56% compared to the previous year's $6.84 billion. Earnings were $226.00 million, a decrease of -44.47%.
Financial StatementsAnalyst Forecast
According to 2 analysts, the average rating for ICL stock is "Hold." The 12-month stock price target is $6.1, which is an increase of 12.34% from the latest price.
News
ICL Announces First Quarter 2026 Earnings Call
TEL AVIV, Israel & ST. LOUIS--(BUSINESS WIRE)--ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals company, today announced it plans to release first quarter 2026 results prior to the ope...
ICL Group Opens Specialty Fertilizer Manufacturing Facility in India, Strengthening Supply Security and Advancing Its Growth Strategy
TEL AVIV, Israel--(BUSINESS WIRE)--ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals company, today announced the opening of a new specialty fertilizer production facility in Maharashtr...
ICL Files 2025 Annual Report on Form 20-F
TEL AVIV, Israel & ST. LOUIS--(BUSINESS WIRE)--ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals company, today announced the filing of its annual report on Form 20-F for the fiscal yea...
ICL Announces Chief Financial Officer Transition
TEL AVIV, Israel--(BUSINESS WIRE)--ICL Group Ltd. (NYSE: ICL) (TASE: ICL), a leading global specialty minerals company, today announced that, as per the resolution of the company's Board of Directors,...
ICL Group Earnings Call Transcript: Q4 2025
Delivered strong 2025 results with 5% sales growth and $1 billion specialty-driven EBITDA. Strategic focus on Specialty Crop Nutrition and Food Solutions, with Bartek acquisition and core asset optimization. 2026 guidance reflects stable potash, ongoing cost and FX risks.
ICL Reports Fourth Quarter and Full Year 2025 Results
TEL AVIV, Israel & ST. LOUIS--(BUSINESS WIRE)--ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals company, today reported its financial results for the fourth quarter and full year ended...
ICL Announces Fourth Quarter 2025 Earnings Call
TEL AVIV, Israel & ST. LOUIS--(BUSINESS WIRE)--ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals company, today announced it plans to release fourth quarter 2025 results prior to the op...
ICL Group Transcript: Investor update
A binding agreement with Israel finalizes asset valuation at $2.54 billion and secures operational continuity and compensation terms through 2035. The new concession process will begin with prequalification in 2026, with selection targeted for 2027.
ICL Group Expands Further into Global Food Ingredients with Acquisition of Bartek Ingredients
TEL AVIV, Israel & ST. LOUIS--(BUSINESS WIRE)--ICL (NYSE: ICL) (TASE: ICL) today announced it has entered into a definitive agreement to acquire Bartek Ingredients. Bartek is the global leader in food...
ICL Reports Third Quarter 2025 Results and Announces New Strategic Principles
TEL AVIV, Israel & ST. LOUIS--(BUSINESS WIRE)--ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals company, today reported its financial results for the third quarter ended September 30, ...
ICL Announces Third Quarter 2025 Earnings Call
TEL AVIV, Israel & ST. LOUIS--(BUSINESS WIRE)--ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals company, today announced it plans to release third quarter 2025 results prior to the ope...
ICL Group Transcript: Jefferies Mining and Industrials Conference 2025
End markets show gradual improvement, with specialties now driving 70% of revenue and providing stability. Strategic acquisitions and global production reduce tariff risks, while ongoing investments in biologicals, functional ingredients, and R&D support innovation. Capital allocation remains balanced, with bolt-on M&A and a focus on commercializing new specialty products.
ICL to Participate in Fireside Chat at Jefferies Industrials Conference 2025
TEL AVIV, Israel & ST. LOUIS--(BUSINESS WIRE)--ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals company, today announced Anantha Desikan, executive vice president and chief innovation ...
Israel Corp. Reports Results for Second Quarter of 2025
TEL AVIV, Israel , Aug. 13, 2025 /PRNewswire/ -- Israel Corporation Ltd. (TASE: ILCO) ("ILCO") announced today its second quarter results for the period ending June 30, 2025.
ICL Reports Second Quarter 2025 Results
TEL AVIV, Israel & ST. LOUIS--(BUSINESS WIRE)--ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals company, today reported its financial results for the second quarter ended June 30, 2025...
ICL Announces Second Quarter 2025 Earnings Call
TEL AVIV, Israel--(BUSINESS WIRE)--ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals company, today announced it plans to release second quarter 2025 results prior to the opening of the...
Evogene Announces Completion of Transaction for the Sale of Lavie Bio's Activity to ICL
REHOVOT, Israel , July 8, 2025 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company utilizing cutting-edge artificial intelligence and predictive biology ...
Israel Corp. Reports Results for First Quarter of 2025
TEL AVIV, Israel , May 21, 2025 /PRNewswire/ -- Israel Corporation Ltd. (TASE: ILCO) ("ILCO") announced today its first quarter results for the period ending March 31, 2025.
ICL Group Earnings Call Transcript: Q1 2025
First quarter 2025 saw 2% year-over-year sales growth to $1.77B, with specialties and regional businesses driving performance. Potash and Phosphate prices improved sequentially, and guidance for 2025 was maintained, with minimal expected tariff impact.
ICL Reports First Quarter 2025 Results
TEL AVIV, Israel & ST. LOUIS--(BUSINESS WIRE)--ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals company, today reported its financial results for the first quarter ended March 31, 2025...
ICL Announces First Quarter 2025 Earnings Call
TEL AVIV, Israel--(BUSINESS WIRE)--ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals company, today announced it plans to release first quarter 2025 results prior to the opening of the ...
Israel Corp. Reports Results for Fourth Quarter of 2024
TEL AVIV, Israel , March 27, 2025 /PRNewswire/ -- Israel Corporation Ltd. (TASE: ILCO) ("ILCO") announced today its fourth quarter and annual results for the period ending December 31, 2024.
ICL Files 2024 Annual Report on Form 20-F
TEL AVIV, Israel--(BUSINESS WIRE)--ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals company, today announced the filing of its annual report on Form 20-F for the fiscal year ended Dece...
ICL Group Transcript: Bank of America 2025 Global Agriculture and Materials Conference
A fully integrated phosphate business is shifting focus from commodities to high-value specialties, with 60% of revenue now from downstream products. Major growth is targeted in battery materials, especially LFP, with new projects in the US and Europe, and ongoing M&A to expand specialty offerings.
ICL Group Earnings Call Transcript: Q4 2024
2024 saw strong specialties-driven EBITDA growth, robust cash flow, and market share gains despite potash price declines and geopolitical challenges. Guidance for 2025 anticipates higher potash prices, continued innovation, and disciplined capital allocation.